These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 15120837)

  • 1. Diuretic use, progressive heart failure, and death in patients in SOLVD.
    Ghali JK
    J Am Coll Cardiol; 2004 May; 43(9):1723; author reply 1723. PubMed ID: 15120837
    [No Abstract]   [Full Text] [Related]  

  • 2. Diuretic use, progressive heart failure, and death in patients in the Studies Of Left Ventricular Dysfunction (SOLVD).
    Domanski M; Norman J; Pitt B; Haigney M; Hanlon S; Peyster E;
    J Am Coll Cardiol; 2003 Aug; 42(4):705-8. PubMed ID: 12932605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aldosterone blockade in patients with heart failure and a reduced left ventricular ejection fraction.
    Pitt B
    Eur Heart J; 2009 Feb; 30(4):387-8. PubMed ID: 19190013
    [No Abstract]   [Full Text] [Related]  

  • 4. Diuretic use, progressive heart failure, and death in patients in the DIG study.
    Domanski M; Tian X; Haigney M; Pitt B
    J Card Fail; 2006 Jun; 12(5):327-32. PubMed ID: 16762792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Diastolic dysfunction and diastolic heart failure].
    Rossi G
    Recenti Prog Med; 2007; 98(7-8):407-16. PubMed ID: 17685191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The importance of heart rate recovery in patients with heart failure or left ventricular systolic dysfunction.
    Lipinski MJ; Vetrovec GW; Gorelik D; Froelicher VF
    J Card Fail; 2005 Oct; 11(8):624-30. PubMed ID: 16230267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Left ventricular conditioning in the elderly patient to prevent congestive heart failure after transcatheter closure of atrial septal defect.
    Schubert S; Peters B; Abdul-Khaliq H; Nagdyman N; Lange PE; Ewert P
    Catheter Cardiovasc Interv; 2005 Mar; 64(3):333-7. PubMed ID: 15736252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug therapy for chronic heart failure due to left ventricular systolic dysfunction. II. Diuretics.
    Fortuna P; Reis I; Ascenção R; Carneiro AV
    Rev Port Cardiol; 2008; 27(7-8):977-89. PubMed ID: 18959094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment practices in heart failure with preserved left ventricular ejection fraction: a prospective observational study.
    Peltier M; Houpe D; Cohen-Solal A; Béguin M; Levy F; Tribouilloy C
    Int J Cardiol; 2007 Jun; 118(3):363-9. PubMed ID: 17049391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diuretic therapy in elderly heart failure patients with and without left ventricular systolic dysfunction.
    van Kraaij DJ; Jansen RW; Gribnau FW; Hoefnagels WH
    Drugs Aging; 2000 Apr; 16(4):289-300. PubMed ID: 10874524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treating diastolic failure: the role of diuretics and nitrates.
    Fonseca C
    Rev Port Cardiol; 1999 Sep; 18 Suppl 5():V107-10. PubMed ID: 10582471
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of diabetes mellitus and ischemic heart disease on the progression from asymptomatic left ventricular dysfunction to symptomatic heart failure: a retrospective analysis from the Studies of Left Ventricular Dysfunction (SOLVD) Prevention trial.
    Das SR; Drazner MH; Yancy CW; Stevenson LW; Gersh BJ; Dries DL
    Am Heart J; 2004 Nov; 148(5):883-8. PubMed ID: 15523322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Chronic left heart failure. A focus on the pathogenetic basis of medical treatment].
    Novosel MK; Haghfelt TH
    Ugeskr Laeger; 2006 May; 168(19):1854-6. PubMed ID: 16756801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dose-dependent association between use of loop diuretics and mortality in advanced systolic heart failure.
    Chuen MJ; MacFadyen RJ
    Am J Cardiol; 2006 Nov; 98(10):1416-7. PubMed ID: 17134642
    [No Abstract]   [Full Text] [Related]  

  • 15. Mortality and morbidity remain high despite captopril and/or Valsartan therapy in elderly patients with left ventricular systolic dysfunction, heart failure, or both after acute myocardial infarction: results from the Valsartan in Acute Myocardial Infarction Trial (VALIANT).
    White HD; Aylward PE; Huang Z; Dalby AJ; Weaver WD; Barvik S; Marin-Neto JA; Murin J; Nordlander RO; van Gilst WH; Zannad F; McMurray JJ; Califf RM; Pfeffer MA;
    Circulation; 2005 Nov; 112(22):3391-9. PubMed ID: 16301343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantification of the risk and predictors of hyperkalemia in patients with left ventricular dysfunction: a retrospective analysis of the Studies of Left Ventricular Dysfunction (SOLVD) trials.
    de Denus S; Tardif JC; White M; Bourassa MG; Racine N; Levesque S; Ducharme A
    Am Heart J; 2006 Oct; 152(4):705-12. PubMed ID: 16996842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eplerenone: new drug. Recent myocardial infarction with heart failure: a spironolactone me too.
    Prescrire Int; 2006 Apr; 15(82):46-9. PubMed ID: 16604728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of heart failure with abnormal left ventricular systolic function in the elderly.
    Aronow WS
    Clin Geriatr Med; 2007 Feb; 23(1):61-81. PubMed ID: 17126755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. National patterns of use and effectiveness of angiotensin-converting enzyme inhibitors in older patients with heart failure and left ventricular systolic dysfunction.
    Masoudi FA; Rathore SS; Wang Y; Havranek EP; Curtis JP; Foody JM; Krumholz HM
    Circulation; 2004 Aug; 110(6):724-31. PubMed ID: 15289383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathophysiology of heart failure following myocardial infarction.
    Struthers AD
    Heart; 2005 May; 91 Suppl 2(Suppl 2):ii14-6; discussion ii31, ii43-8. PubMed ID: 15831601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.